In October 2021, Penn spinout Interius BioTherapeutics signed a 17,743 SF lease in the Pennovation Lab facility within the Pennovation Works innovation ecosystem. Interius, co-founded by Saar Gill, MD, PhD, Associate Professor of Medicine at the University of Pennsylvania, is developing new ways to transform cell and gene therapy through direct patient administration of genetic medicines to generate therapeutic immune and blood cells.
“The Interius team started its journey in an Inventor Garage with a few lab benches at the Pennovation Center, and in a matter of months, expanded into the Pennovation Lab building. Supported by their Series A raise, the company’s growth over the past few months has been meteoric, and we are delighted to support the team as it grows within our ecosystem” said Anish Kumar, former Managing Director of Pennovation Works. To learn more about Interius read here.
